Financial Performance - The company's operating revenue for Q1 2023 was ¥74,535,937.15, representing a 9.01% increase compared to ¥68,374,192.97 in the same period last year[3]. - The net profit attributable to shareholders for Q1 2023 was ¥9,369,849.59, reflecting a 17.13% increase from ¥7,999,650.28 year-on-year[3]. - The basic earnings per share for Q1 2023 was ¥0.0474, an increase of 17.04% compared to ¥0.0405 in the same period last year[3]. - Total operating revenue for Q1 2023 was CNY 74,535,937.15, an increase of 9.5% compared to CNY 68,374,192.97 in the same period last year[20]. - Net profit for Q1 2023 was CNY 8,166,481.07, a decrease of 14.0% from CNY 9,504,245.43 in Q1 2022[21]. Cash Flow and Liquidity - The net cash flow from operating activities decreased by 88.23%, amounting to -¥123,663,827.04, primarily due to significant procurement payments related to project implementation[3][8]. - The net cash flow from operating activities for Q1 2023 was -CNY 123,663,827.04, worsening from -CNY 65,698,961.02 in the previous year[23]. - The net cash flow from investment activities was -8,041,955.28 CNY, compared to -59,157,633.29 CNY in the previous period[24]. - The total cash inflow from financing activities was 950,000.00 CNY, down from 162,057,682.29 CNY year-over-year[24]. - The net increase in cash and cash equivalents was -131,280,291.05 CNY, contrasting with an increase of 36,819,969.60 CNY in the previous period[24]. - The ending balance of cash and cash equivalents was 286,252,306.42 CNY, compared to 282,427,415.18 CNY at the end of the previous period[24]. Assets and Liabilities - Total assets at the end of Q1 2023 were ¥1,053,978,845.07, down 10.61% from ¥1,179,034,494.46 at the end of the previous year[4]. - The total liabilities as of Q1 2023 were CNY 208,212,618.27, a decrease from CNY 344,393,015.48 in the previous year[21]. - The company's total liabilities decreased to RMB 199,229,119.66, reflecting a slight reduction compared to the previous period[17]. - The total current liabilities decreased to RMB 199,229,119.66 from RMB 203,802,021.11, showing a reduction of about 2.8%[17]. Equity and Shareholder Information - The company's total equity attributable to shareholders increased by 1.48% to ¥847,278,145.21 from ¥834,950,028.88 at the end of the previous year[4]. - The total equity attributable to shareholders of the parent company was CNY 847,278,145.21, an increase from CNY 834,950,028.88 year-over-year[21]. - The company reported a total of 73,633,332 shares under lock-up agreements, with 60,318,434 shares held by the controlling shareholder, China Academy of Sciences Holdings Co., Ltd.[12]. - The company has committed to not transferring shares for 18 months following the issuance of new shares on December 10, 2021[13]. Expenses and Costs - Total operating costs for Q1 2023 were CNY 72,377,873.78, up from CNY 63,901,444.31, reflecting a year-over-year increase of 13.0%[20]. - Research and development expenses for Q1 2023 were CNY 5,739,796.03, down from CNY 6,772,538.26, indicating a reduction of 15.3%[21]. - Sales expenses increased to CNY 10,291,018.00 in Q1 2023, compared to CNY 8,636,274.72 in the same period last year, marking a rise of 19.1%[21]. Other Income and Taxation - Other income increased by 82.47% year-on-year, mainly due to an increase in government subsidies received[10]. - The company reported a 129.80% increase in non-operating income, primarily from penalties received for contract breaches[10]. - The company experienced a 135.17% increase in taxes and surcharges compared to the same period last year, mainly due to an increase in value-added tax surcharges[7]. Audit Status - The company’s first-quarter report was not audited[25].
中科信息(300678) - 2023 Q1 - 季度财报